recent news

[Titch]

Originally Posted by Ray

"1-discontinuation of CFC beclametasone, and the use of Brand products instead i.e Clenil or Qvar, with Qvar having double the potency of Clenil."

wondering how will we be paid for proviing Clenil 250 for a script saying beclametasone 250 mcg?
if it's been endorsed as Clenil 250, do we have to do extra arrangment to get paid for the brand product or PPA will automatically pay us for Clenil?

thanks in advance

If script says beclometasone 250mcg cfc-free you will be paid for Clenil

If the Rx does not mention cfc-free then you should still provide the generic cfc-containing inhaler.

More difficult for other strengths of cfc-free generic descriptions when Qvar is an option also - there ethically you should confirm with the prescriber which one is intended (I'm switching all the patients at my practices but Rxing them all by brand and this is recommended by MHRA so GPs should not be using generic descriptions for this very reason)

Qvar only licensed for over 12 years but licence is pending for under 12s and likely to come through in next few months.
Clenil licensed for children but up to age 18 (I think) should be used via a spacer.

[Raoul]

but the whole story about the discontinuation of CFC beclametasone, what i understood from the letter we received that starting from beginning of july, we should provide Clenil or Qvar " after giving out all the cfc beclametasone which we already have given all "

[Titch]

That could be the way that your PCT wants to operate it. Not the most robust system and asking you to provide a different drug to what the GP has actually prescribed.

Wouldn't have a problem following such a system so long as there is a way to inform the GP when a patient has been changed and what to, and so long as all parties involved understand the system.

There is supposed to be sufficient cfc-containing beclometasone available until the end of August but I do believe 250mcg strength is likely to be the first to run out.